Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Part 1: To identify Maximum Tolerated Dose (MTD) levels of LEO 43204 after once daily treatment for two consecutive days Part 2: To evaluate the efficacy of LEO 43204 in two doses after once daily treatment for two consecutive days compared to vehicle
Epistemonikos ID: b9a42e2833e7ee9aa04feadc80ce2b20d09bcb37
First added on: May 11, 2024